TP53 and breast cancer: Our data also support previous findings that metabolic reprogramming may depend on several intrinsic cues such as breast cancer subtype, ERα/β expression and p53 mutation state as lysine exposure affected different mechanism leading to increased dissemination in luminal A and luminal B BC cells respectively (37).